Cargando…
Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer
BACKGROUND: Despite major advances in lung cancer treatment, early detection remains the most promising way of improving outcomes. To detect lung cancer in earlier stages, many serum biomarkers have been tested. Unfortunately, no single biomarker can reliably detect lung cancer. We combined a set of...
Autores principales: | Yoon, Ho Il, Kwon, Oh-Ran, Kang, Kyung Nam, Shin, Yong Sung, Shin, Ho Sang, Yeon, Eun Hee, Kwon, Keon Young, Hwang, Ilseon, Jeon, Yoon Kyung, Kim, Yongdai, Kim, Chul Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Cancer Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051593/ https://www.ncbi.nlm.nih.gov/pubmed/27722145 http://dx.doi.org/10.15430/JCP.2016.21.3.187 |
Ejemplares similares
-
Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer
por: Yoon, Ho Il, et al.
Publicado: (2016) -
Clinical Profile and Visual Outcomes after Treatment in Patients with Dysthyroid Optic Neuropathy
por: Jeon, Chan, et al.
Publicado: (2012) -
The Usefulness of Procalcitonin and C-Reactive Protein as Early Diagnostic Markers of Bacteremia in Cancer Patients with Febrile Neutropenia
por: Kim, Dae Yong, et al.
Publicado: (2011) -
An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas
por: Kim, Bora, et al.
Publicado: (2013) -
Histopathology and expression of the chemokines CXCL10, CXCL13, and CXCR3 and the endogenous TLR-4 ligand S100A8/A9 in lymph nodes of patients with adult-onset Still’s disease
por: Kim, Hyoun-Ah, et al.
Publicado: (2019)